Quantitative monitoring of CMV viral load in management of CMV reactivations in patients after allogeneic transplantation

被引：0
|
作者：
Hubacek, P [1 ]
Sedlacek, P [1 ]
Hyncicova, K [1 ]
Cinek, O [1 ]
Skapa, P [1 ]
Keslova, P [1 ]
Formankova, R [1 ]
Stary, J [1 ]
机构：
[1] Univ Hosp Motol, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [1] Is quantitative evaluation of CMV viral load using Taqman™ quantitative CMV PCR (Taqman™ CMVQ PCR) valuable in the management of CMV in patients following stem cell transplantation?
    Ewing, JC
    Mutton, K
    Guiver, M
    Chang, J
    Morgenstern, GR
    Williams, CD
    Chopra, R
    [J]. BLOOD, 2001, 98 (11) : 394A - 394A
  • [2] Comparison of quantitative CMV-PCR in plasma and CMV antigenaemia assay in monitoring patients after allogeneic stem cell transplantation
    Picardi, A
    Gentile, G
    de Fabritiis, P
    Capobianchi, A
    Cudillo, L
    Dentamaro, T
    Tendas, A
    Cupelli, L
    Ciotti, M
    Volpi, A
    Amadori, S
    Martino, P
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S198 - S198
  • [3] Risk factors for development of CMV disease after allogeneic stem cell transplantation in the era of viral load monitoring
    Ljungman, P
    Pérez-Bercoff, L
    Jonsson, J
    Sparrelid, E
    Aschan, J
    Barkholt, L
    Larsson, K
    Lewensohn-Fuchs, I
    Winiarski, J
    Yun, Z
    Ringdén, O
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S27 - S27
  • [4] CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation
    Alam, Naheed
    Lambie, Anna
    Yunes, Yvette Neme
    Alfraih, Feras
    Atenafu, Eshetu G.
    Kim, Dennis Dong Hwan
    Gupta, Vikas
    Kuruvilla, John
    Lipton, Jeff H.
    Messner, Hans A.
    [J]. BLOOD, 2012, 120 (21)
  • [5] Viral load as risk factor for development of CMV disease after allogeneic stem cell transplantation
    Ljungman, P
    Jonsson, J
    Sparrelid, E
    Aschan, J
    Barkholt, L
    Larsson, K
    Lewensohn-Fuchs, I
    Winiarski, J
    Yun, Z
    Ringdén, O
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S24 - S24
  • [6] Effect of the donor CMV status on CMV reactivation after allogeneic transplantation
    Nürnberger, W
    Krempe, C
    Steinhagen, G
    Adams, O
    Göbel, U
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [7] Standardization of CMV DNA Viral Load Monitoring
    Cobb, B.
    Boisvert, D.
    Lee, S.
    Baum, P.
    Razonable, R.
    Caliendo, A.
    Asberg, A.
    Yao, J.
    Do, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 210 - 211
  • [8] CMV viral load kinetics as surrogate endpoints after allogenic transplantation
    Duke, Elizabeth R.
    Williamson, Brian D.
    Borate, Bhavesh
    Golob, Jonathan L.
    Wychera, Chiara
    Stevens-Ayers, Terry
    Huang, Meei-Li
    Cossrow, Nicole
    Wan, Hong
    Mast, T. Christopher
    Marks, Morgan A.
    Flowers, Mary E.
    Jerome, Keith R.
    Corey, Lawrence
    Gilbert, Peter B.
    Schiffer, Joshua T.
    Boeckh, Michael
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01):
  • [9] Comparison of CMV antigenaemia and quantitative realtime PCR CMV-DNA assay in the detection of CMV infection in patients after allogeneic haematopoietic stem cell transplantation
    Gozdzik, J.
    Mordel, A.
    Lesko, E.
    Krasowska-Kwiecien, A.
    Kacinska, E.
    Wedrychowicz, A.
    Czogala, W.
    Wiecha, O.
    Skoczen, S.
    Majka, M.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S176 - S176
  • [10] CMV and EBV Reactivation after Allogeneic Transplantation
    Butler, Andrew
    Thurston, Andrew
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S244 - S244
12345